Bruker's Revenues Jump 27 Percent in Q4 as Service and Product Sales Up | GenomeWeb
NEW YORK (GenomeWeb News) — Bruker BioSciences today said fourth-quarter revenues increased 27 percent as R&D spending rose 23 percent and profit nearly doubled.
 
Total receipts for the three months ended Dec. 31, 2006, increased to $135.6 million from $106.7 million year over year.
 
Product revenue increased 25 percent to $120.4 million; service revenue increased 45 percent to $15 million; and “other” revenue decreased 48 percent to $146,000.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.